Epigenetic events in liver cancer resulting from alcoholic liver disease

Alcohol Research: Current Reviews

Volumn 35, Issue 1, 2013, Pages 57-67

  French, Samuel W ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Alcohol abuse; Alcohol consumption; Alcoholic liver disease; Chronic alcohol use; DNA methylation; Epigenetic mechanisms; Epigenetics; Ethanol metabolism; Hepatocellular carcinoma; Histone methylation; Liver cancer; Micro RNAs; Stem cells

Indexed keywords

EID: 84881487238     PISSN: 21683492     EISSN: 21694796     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Abbas, T., and Dutta, A. CRL4Cdl2: Master coordinator of cell cycle progression and genome stability. Cell Cycle 10(2):241-249, 2011. PMiD: 21212733
2. Alison, M.R.; Islam, S.; and Lim, S. Stem cells in liver regeneration, fibrosis and cancer: The good, the bad and the ugly. Journal of Pathology 217(2):282-298, 2009. PMID: 18991329
3. Bardag-Gorce, F.; French, B.A.; Joyce, M.; et al. Histone acetyltransferase p300 gene expression in an epigenetic manner at high blood alcohol levels. Experimental and Molecular Pathology 82(2):197-202, 2007. PMiD: 17208223
4. Bardag-Gorce, F.; French, B.A.; Nan, L.; et al. CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation. Experimental and Molecular Pathology 81(3):191-201, 2006. PMiD: 17034788
5. Bardag-Gorce, F.; oliva, J.; Dedes, J.; et al. Chronic ethanol feeding alters hepatocyte memory which is not altered by acute feeding. Alcoholism: Clinical and Experimental Research 33(4):684-692, 2009. PMiD: 19170665
6. Bardag-Gorce, F.; Oliva, J.; Lin, A.; et al. SAMe prevents the up regulation of toll-like receptor signaling in Mallory-Denk body forming hepatocytes. Experimental and Molecular Pathology 88(3):376-379, 2010. PMiD: 20206621
7. Bardag-Gorce, F.; Oliva, L.; Villegas, J.; et al. Epigenetic mechanisms regulate Mallory Denk body formation in the livers of drug-primed mice. Experimental and Molecular Pathology 84(2):113-121, 2008. PMiD: 18281034
8. Braconi, C., and Patel, T. MicroRNA expression profiling: A molecular tool for defining the phenotype of hepatocellular tumors. Hepatology 47(6): 1807-1809, 2008. PMiD: 18506877
9. Cheng, A.S.; Lan, S.S.; Chen, Y.; et al. EZH2-mediated concordant repression of Wnt antagonists promotes p-catenin-dependent hepatocarcinogenesis. Cancer Research 71(11):4028-4039, 2011. PMiD: 21512140
10. Collas, P. Epigenetic states in stem cells. Biochemica et Biophysica Acta 1790(9):900-905, 2009. PMiD: 19013220
11. Crary, G.S., and Albrecht, J.H. Expression of cyclin- dependent kinase inhibitor p21 in human liver. Hepatology 28(3):738-743, 1998. PMiD: 97311566
12. Crea, F. EZH2 and cancer stem cells: Fact or fiction? Epigenomics 3(2):127-128, 2011. PMiD: 22122274
13. Dokmanovic, M.; Clarke, C.; and Marks, P.A. Histone deacety- lase inhibitors: Overview and perspectives. Molecular Cancer Research 5(10):981-989, 2007. PMiD: 17951399
14. Dolganiuc, A.; Petrasek, J.; Kodys, K.; et al. Micro RNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. Alcoholism: Clinical and Experimental Research 33(10):1704-1710, 2009. PMiD: 19572984
15. Donato, F.; Tagger, A.; Gellati, U.; et al. Alcohol and hepatocellular carcinoma. The effect of lifetime intake and hepatitis virus infections in men and women. American Journal of Epidemiology 155(4):323-331, 2002. PMiD: 11836196
16. Drummond, D.C.; Noble, C.O.; Kirpotin, D.B., et al. Clinical development of histone deacetylase inhibitors as anticancer agents. Annual Review of Pharmacology and Toxicology 45:495-528, 2005. PMiD: 15822187
17. Esfandiari, F.; Medici, V.; Wong, D.H.; et al. Epigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanol-fed cystathionine beta synthase- deficient mouse. Hepatology 51(3):932-941, 2010. PMiD:19957376
18. Fang, Z.; Fu, Y.; Liang, Y.; et al. Increased expression of integrin in p1 subunit enhances p21WAF1/Cip1 transcription through the Sp1 sites and p300-mediated histone acetylation in human hepatocellular carcinoma cells. Journal of Cellular Biochemistry 101(3):654-664, 2007. PMiD: 17211849
19. French, B.A.; Oliva, J.; Bardag-Gorce, F.; et al. Mallory-Denk bodies form when EZH2/H3K27me3 fails to methy-late DNA in the nuclei of human and mice liver cells. Experimental and Molecular Pathology 92(3):318-326, 2012. PMiD: 22465358
20. French, S.W.; Bardag-Gorce, F.; French, B.A.; et al. The role of innate immunity in the pathogenesis of preneoplasia in drug-induced chronic hepatitis based on a mouse model. Experimental and Molecular Pathology 91(3):653-659, 2011. PMiD: 21820428
21. French, S.W.; Bardag-Gorce, F.; Li, J.; et al. Mallory-Denk body pathogenesis revisited. World Journal of Hepatology 2(8):295-301, 2010. PMiD: 21161012
22. Furuta, M.; Kozaki, K.I.; Tanaka, S.; et al. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31(5):766-776, 2009. PMiD: 19843643
23. Gieni, R.S., and Hendzel, M.J. Polycomb group protein gene silencing, non-coding RNA, stem cells, and cancer. Biochemistry and Cell Biology 87(5):711-746, 2009. PMiD: 19898523
24. Gui, C.Y.; Ngo, L.; Xu, W.S.; et al. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proceedings of the National Academy of Sciences of the United States of America 101(5):1241-1246, 2004. PMiD: 14734806
25. Hamilton, J.P. Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies. Epigenomics 2(2):233-243, 2010. PMiD: 20556199
26. Hassan, M.M.; Hwang, L.Y.; Hatten, C.J.; et al. Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 36(5): 1206-1213, 2002. PMiD: 12395331
27. Hitchler, M.J., and Domann, F.E. Metabolic defects provide a spark for the epigenetic switch in cancer. Free Radical Biology & Medicine 47(2):115-127, 2009. PMiD: 19362589
28. Iacobuzio-Donohue, C.A. Epigenetic changes in cancer. Annual Review of Pathology 4:229-249, 2009. PMiD: 18840073
29. Koteish, A.; Yang, S.; Lin, H.; et al. Ethanol induces redox- sensitive cell-cycle inhibitors and inhibits liver regeneration after partial hepatectomy. Alcoholism: Clinical and Experimental Research 26(11):1710-1718, 2002. PMiD:12436061
30. Ladeiro, Y.; Couchy, G.; Balabaud, C.; et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor mutations. Hepatology 47(6):1955-1963, 2008. PMiD: 18433021
31. Lennartsson, A., and Ekwall, K. Histone modification patterns and epigenetic codes. Biochemica et Biophysica Acta 1790(9):863-868, 2009. PMiD: 19168116
32. Loomba, R.; Yang, H.I.; Su, J.; et al. Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men. Clinical Gastroenterology and Hepatology 8(10):891-898, 2010. PMiD: 20621202
33. Lu, L.; Li, L.; Lu, X.; et al. Inhibition of SIRT1 increases EZH2 protein level and enhances the repression of EZH2 on target gene expression. Chinese Medical Sciences Journal 26(2):77-84, 2011. PMiD: 21703114
34. Lu, S.C.; Ramani, K.; Ou, X.; et al. S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model. Hepatology 50(2):462-471, 2009. PMiD: 19444874
35. Machida, K.; Tsukamoto, H.; Mkrtchyan, H.; et al. Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog. Proceedings of the National Academy of Sciences of the United States of America 106(5):1548-1553. PMID: 19171902
36. Machida, K.; Chen, C.L.; Liu, J.C.; et al. Cancer stem cells generated by alcohol, diabetes and hepatitis C virus. Journal of Gastroenterology and Hepatology 27(Suppl. 2):19-22, 2012. PMiD: 22320911
37. Mandrekar, P. Epigenetic regulation in alcoholic liver disease. World Journal of Gastroenterology 17(20):2456-2464, 2011. PMiD: 21633650
38. Mohamed, A.E.; Kew, M.C.; and Groeneveld, H.T. Alcohol consumption as a risk factor for hepatocellular carcinoma in urban Southern Africa Blacks. International Journal of Cancer 51(4):537-541, 1992. PMiD: 1318267
39. Morgan, T.R.; Mandayam, S.; and Jamal, M.M. Alcohol and hepatocellular carcinoma. Gastroenterology 127(5 Suppl 1):S87-S96, 2004. PMiD: 15508108
40. Muntean, A.G., and Hess, J.L. Epigenetic dysregulation in cancer. American Journal of Pathology 175(4):1353-1361, 2009. PMiD: 19717641
41. Murakami, Y.; Yasuda, T.; Saigq, K.; et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25(17):2537-2545, 2006. PMiD: 16331254
42. Ohm, J.E., and Baylin, S.B. Stem cell chromatin patterns and DNA hypermethylation in cancer drug discovery and development. in: Bagley, R.G., and Teicher, B.A., eds. Stem Cells and Cancer. New York: Humana Press, 2009, pp. 85-97.
43. Oliva, J., and French, S.W. Changes in IL12A methylation pattern in livers from mice fed DDC. Experimental and Molecular Pathology92(2): 191-193, 2012. PMiD: 22273483
44. Oliva, J.; Bardag-Gorce, F.; French, B.A.; et al. FAT10 is an epigenetic marker for liver preneoplasia in a drug- primed mouse model of tumorigenesis. Experimental and Molecular Pathology 84(2):102-112, 2008. PMiD: 18280469
45. Oliva, J.; French, B.A.; Qing, X.; and French, S.W. The identification of stem cells in human liver diseases and hepatocellular carcinoma. Experimental and Molecular Pathology 88(3):331-340, 2010. PMiD: 20080086
46. Oliva, J.; Zhong, J.; Buslon, V.S.; and French, S.W. The effect of SAMe and betaine on Hepa 1-6, C34 and E47 liver cell survival in vitro. Experimental and Molecular Pathology92(1):126-130, 2012. PMiD: 22032937
47. Pqgribny, I.P. MicroRNA dysregulation during chemical carcinogenesis. Epigenomics 1(2):281-290, 2009. PMiD:22122703
48. Richly, H.; Lange, M.; Simboeck, E.; and Croce, L. Setting and resetting of epigenetic marks in malignant transformation and development. Bioassays 32(8):669-679. PMiD: 20658705
49. Sasaki, Y. Does oxidative stress participate in the development of hepatocellular carcinoma? Journal of Gastroenterology 41(12):1135-1148, 2006. PMiD: 17287893
50. Sawan, C.; Vaissiere, T.; Murr, R.; and Herceg, Z. Epigenetic drivers and genetic passengers on the road to cancer. Mutation Research 642(1-1):1-13, 2008. PMiD: 18471836
51. Seitz, H.K., and Stickel, F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nature Reviews. Cancer 7(8):599-612, 2007. PMiD: 17646865
52. Serres, M.P.; Kossatz, u.; Chi, Y.; et al. p27 (Kip1) controls cytokinesis via the regulation of citron kinase activation. Journal of Clinical Investigation 122(3):844-858, 2012. PMiD: 22293177
53. Serres, M.P.; Zlotek-Zlotkiewicz, E.; Concha, C.; et al. Cytoplasmic p27 is oncogenic and cooperates with Ras both in vivo and in vitro. Oncogene 30(25):2846-2858. PMiD: 21317921
54. Starland-Davenport, A.; Tryndyak, V.; Kosyk, O.; et al. Dietary methyl deficiency, microRNA expression and susceptibility to liver carcinogenesis. Journal of Nutrigenetics and Nutrigenomics 3(4-6):259-266, 2010. PMiD: 21474957
55. Tagger, A.; Donato, F.; Ribero, M.L.; et al. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: The role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Bresica HCC Study. International Journal of Cancer 81(5):695-699, 1999. PMiD: 10328218
56. Villasante, A.; Piazzolla, D.; Li, H.; et al. Epigenetic regulation of Nanog expression by EZH2 in pluripotent stem cells. Cell Cycle 10(9):1488-1498, 2011. PMiD: 21490431
57. Weitzman, S.A.; Turk, P.W.; Milowski, D.H.; and Kozlowski, K. Free radical adducts induce alterations in DNA cytosine methylation. Proceedings of the National Academy of Sciences of the United States of America 91(4): 1261-1264, 1994. PMiD: 8108398
58. Wong, C.M.; Yam, J.W.; and Ng, I.O. Molecular Pathogenesis of hepatocellular carcinoma. in: Wang, X.W.; et al., (eds). Molecular Genetics in Liver Neoplasms, Cancer Genetics. New York: Springer Science and Business Media, LLC, pp. 373-396, 2010.
59. Wu, Y.; Nan, L.; Bardag-Gorce, F.; et al. The role of laminin- integrin signaling in triggering MB formation. An in vivo and in vitro study. Experimental and Molecular Pathology 79(1):1-8. 2005. PMiD: 15896771
60. Yu, K.R.; Yang, S.R.; Jung, J.W.; et al. CD49f enhances multipotency and maintains stemness through the direct regulation of OCT4 and SOX2. Stem Cells 30(5):876-887, 2012. PMiD: 2231137
61. Zampetaki, A.; Xiao, Q.; Zeng, L.; et al. TLR4 expression in mouse embryonic stem cells and in stem cell-derived vascular cells is regulated by epigenetic modifications. Biochemical and Biophysical Research Communications 347(1):87-99, 2006. PMiD: 16814255